Primary Record
Orteronel
- In stock
- 9,383 g
- Purity
- 99.4 %
- CAS
- 566939-85-3
Compound Identifiers & Properties
- CAS
- 566939-85-3
- PubChem CID
- 9796590
- SMILES
- CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)[C@]3(CCN4C3=CN=C4)O
- Canonical SMILES
- CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1
Names & Synonyms
- Orteronel
- orteronelum
- TAK-700
- 566939-85-3
- (S)-Orteronel
- Orteronel [INN]
- (+)-orteronel
- TAK700
- TAK 700
- TAK-700 (Orteronel)
- Orteronel [USAN:INN]
- UE5K2FNS92
- ORTERONEL [JAN]
- UNII-UE5K2FNS92
- Orteronel (JAN/USAN)
- ORTERONEL [USAN]
- TAK-700 R-form
- RefChem:856930
- TAK-700 - Orteronel
- ORTERONEL [WHO-DD]
- TAK700 (S-Enantiomer)
- TAK-700 (S-form)
- CHEMBL1921976
- cc-589
- C18H17N3O2
- DTXSID001319121
- orb1689515
- SCHEMBL6126076
- 566939-85-3,Orteronel
- SCHEMBL29363567
- GTPL13853
- S-TAK-700
- AOB5527
- EX-A159
- 566939-85-3 (s-isomer)
- CHEBI:231353
- MFCD20528078
- (S)-TAK700
- csa:566939-85-3;Orteronel
- DTXCID101748551
- GLXC-06640
- HMS3750I13
- RXA93985
- ZINC3943521
- Orteronel,CAS:566939-85-3
- BDBM50358201
- CYP17A1 Inhibitor II, TAK-700
- CYP17A1 Lyase Inhibitor TAK-700
- AKOS030526849
- Androgen Synthesis Inhibitor TAK-700
- CID9796590
- CS-0580
- DB12066
- RL04142
- SB16686
- (+)-TAK-700
- CID:9796590
- NCGC00378767-02
- (S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide
- AJ-47464
- AS-74591
- HY-10505
- SID:312856262
- AB0165761
- A3686
- A4326
- B1194
- NS00069633
- compound (+)-3c [PMID: 21978946]
- J2.839.701A
- 6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide
- A23200
- A25522
- D10146
- S-7761
- A869867
- A903530
- C571806
- 6-[(7S)-7-HYDROXY-6,7-DIHYDRO-5H-PYRROLO[1,2-C]IMIDAZOL-7-YL]-N-METHYL-2-NAPHTHALENECARBOXAMIDE
- 6-((7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthalenecarboxamide
- 426219-18-3
- 426219-53-6
- 6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide
- 6-((7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthamide
- 6-[(7S)-7-hydroxy-5H,6H,7H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide
- (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide
- 6-[(7s)-7-hydroxy-6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide
- 6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazole-7-yl]-N-methyl-2-naphthamide
- 7-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide
- N-Methyl-6-[(7S)-7-hydroxy-5,6-dihydro-7H-pyrrolo[1,2-c]imidazole-7-yl]-2-naphthamide
- 2-NAPHTHALENECARBOXAMIDE, 6-((7S)-6,7-DIHYDRO-7-HYDROXY-5H-PYRROLO(1,2-C)IMIDAZOL-7-YL)-N-METHYL-
- 426219-23-0
- 6-((7S)-7-hydroxy-5H,6H,7H-pyrrolo(1,2-c)imidazol-7-yl)-N-methylnaphthalene-2-carboxamide
- 6-(6-hydroxy-1,3-diazabicyclo[3.3.0]octa-2,4-dien-6-yl)-N-methyl-naphthalene-2-carboxamide
- 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- 6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methyl-naphthalene-2-carboxamide
- 752243-39-3
- N-Methyl-6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazole-7-yl]naphthalene-2-carboxamide